{"url":"https://lda.senate.gov/api/v1/filings/a2ea0e8a-e51c-4c6e-8570-c8143cd7d571/","filing_uuid":"a2ea0e8a-e51c-4c6e-8570-c8143cd7d571","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2012,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a2ea0e8a-e51c-4c6e-8570-c8143cd7d571/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James B. Christian, Partner","dt_posted":"2012-04-18T06:48:58.157000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2550 M STREET, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":30906,"url":"https://lda.senate.gov/api/v1/registrants/30906/","house_registrant_id":31917,"name":"SQUIRE PATTON BOGGS","description":"Law Firm","address_1":"2550 M STREET, NW","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GLENN WILLARD","contact_telephone":"+1 202-457-6000","dt_updated":"2026-07-10T16:40:57.961456-04:00"},"client":{"id":137497,"url":"https://lda.senate.gov/api/v1/clients/137497/","client_id":1007681,"name":"MELA SCIENCES, INC.","general_description":"medical technology company","client_government_entity":false,"client_self_select":false,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-03-07"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"FDA regulatory procedures with respect to melanoma detection systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":16152,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"YAROWSKY","suffix":null,"suffix_display":null},"covered_position":"GCHouseJudCom82-95; SACPres95-98","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}